查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1720777

2025年全球糖尿病診斷市場報告

Diabetes Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年糖尿病診斷市場規模將強勁成長。到 2029 年，這一數字將成長至 367.2 億美元，複合年成長率為 7.6%。預測期內的成長歸因於胰島素幫浦的普及、糖尿病技術的進步、不健康生活習慣的盛行、1 型和 2 型糖尿病患者數量的快速增加以及醫療保健基礎設施的擴展。主要趨勢包括生物感測器技術的進步、診斷技術的創新、個人化醫療和標靶治療的興起以及先進體外診斷技術的發展。

預計未來幾年肥胖率的上升將推動糖尿病診斷市場的成長。肥胖的特徵是體內脂肪過度堆積，會增加罹患多種健康疾病的風險，包括心臟病和糖尿病。肥胖發病率的上升與久坐不動的生活方式、加工食品和高熱量食品的消費量增加、遺傳傾向和體力活動減少等因素有關。糖尿病診斷在肥胖管理中發揮關鍵作用，可以早期發現胰島素阻抗和葡萄糖代謝問題，從而及時干預，防止體重增加和相關的健康併發症。例如，美國政府機構疾病管制與預防中心於2023年9月報告稱，2022年成人肥胖率達到或超過35%的州有22個，高於2021年的19個州。肥胖率的上升正在促進糖尿病診斷市場的擴張。

糖尿病診斷市場中的公司正在擴大其產品組合，並專注於開發妊娠糖尿病診斷工具等創新產品，以滿足對妊娠糖尿病早期檢測和管理日益成長的需求。這些工具包括用於檢測和監測孕婦妊娠糖尿病的醫療設備和測試，通常涉及血糖測試，如口服葡萄糖耐受測試 (OGTT)，以評估身體在懷孕期間如何處理糖分。例如，2024 年 8 月，奧地利生物技術公司 DirectSens GmbH 推出了 XpressGT RUO套件，這是一種用於檢測與胰島素抗性相關的疾病（例如妊娠期糖尿病、子宮內膜異位症和肝病）的尖端生物感測器工具。該套件透過測量靜脈血液中的 2-羥基丁酸 (2-HB) 水平來快速提供結果，並與標準臨床分析儀相容。這項創新可以促進早期診斷並改善全球數百萬名患者的健康狀況。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 - 市場 - 宏觀經濟情境 宏觀經濟情境包括利率、通膨、地緣政治以及感染疾病和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球糖尿病診斷PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球糖尿病診斷市場：成長率分析
  • 全球糖尿病診斷市場表現：規模與成長，2019-2024
  • 全球糖尿病診斷市場預測：規模與成長，2024-2029 年，2034 年
  • 全球糖尿病診斷總目標市場（TAM）

第6章市場區隔

  • 全球糖尿病診斷市場：依產品類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 血糖測量裝置
  • 連續血糖監測裝置
  • 《採血針》
  • 測試條
  • 其他產品類型
  • 全球糖尿病診斷市場（依糖尿病類型、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 糖尿病
  • 2型糖尿病
  • 妊娠糖尿病
  • 全球糖尿病診斷市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診斷中心
  • 居家照護環境
  • 其他最終用戶
  • 全球糖尿病診斷市場細分（按血糖儀類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 常規血糖測量裝置
  • 智慧型血糖儀
  • 藍牙血糖監測儀
  • 全球糖尿病診斷市場連續血糖監測設備細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 穿戴式CGM系統
  • 植入式CGM系統
  • Flash血糖監測儀
  • 全球糖尿病診斷市場依採血針類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 免稍後採血針
  • 多用途採血針
  • 全球糖尿病診斷市場，按試紙類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 標準試紙
  • 智慧試紙
  • 全球糖尿病診斷市場，按其他產品類型細分，按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 糖化血紅素 A1c檢測套組
  • 尿糖試紙
  • 血酮儀

第7章 區域和國家分析

  • 全球糖尿病診斷市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球糖尿病診斷市場：依國家、表現及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 糖尿病診斷市場：競爭格局
  • 糖尿病診斷市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Novartis AG
  • 3M Company
  • Medtronic plc
  • Regeneron Pharmaceuticals Inc.
  • Carl Zeiss Meditec AG
  • Bausch & Lomb Incorporated
  • DexCom Inc
  • Santen Pharmaceutical Co. Ltd.
  • Topcon Corporation
  • Tandem Diabetes Care Inc
  • Ypsomed AG
  • LifeScan Inc
  • Nova Biomedical Corporation
  • Ascensia Diabetes Care Holdings AG
  • ARKRAY Inc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年糖尿病診斷市場：提供新機會的國家
  • 2029年糖尿病診斷市場：細分市場將帶來新機會
  • 2029年糖尿病診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r34033

Diabetes diagnostics encompasses the methods and tests used to detect and monitor diabetes by measuring blood glucose levels and other relevant biomarkers. These assessments help identify abnormal glucose metabolism, assess diabetes risk or presence, and support early detection, disease management, and treatment planning.

The primary product types in diabetes diagnostics include blood glucose meters, continuous glucose monitoring devices, lancets, test strips, and others. Blood glucose meters are portable medical devices that measure blood sugar levels by analyzing a small drop of blood, usually from a fingertip, placed on a test strip. These devices are used for Type I diabetes, Type II diabetes, and gestational diabetes across various settings, including hospitals, diagnostic centers, home care, and others.

The diabetes diagnostics market research report is one of a series of new reports from The Business Research Company that provides diabetes diagnostics market statistics, including the diabetes diagnostics industry global market size, regional shares, competitors with the diabetes diagnostics market share, detailed diabetes diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the diabetes diagnostics industry. This diabetes diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diabetes diagnostics market size has grown strongly in recent years. It will grow from $25.39 billion in 2024 to $27.39 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth during the historic period can be credited to the rising prevalence of diabetes, an expanding geriatric population, increasing sedentary lifestyles, greater adoption of minimally invasive diagnostics, and the growing prevalence of obesity.

The diabetes diagnostics market size is expected to see strong growth in the next few years. It will grow to $36.72 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be credited to the rising adoption of insulin pumps, advancements in diabetes technology, increasing prevalence of unhealthy lifestyles, a surge in Type 1 and Type 2 diabetes cases, and the expansion of healthcare infrastructure. Key trends include advancements in biosensor technology, innovations in diagnostic technologies, the rise of personalized medicine and targeted therapies, and the development of advanced in vitro diagnostic products.

The increasing prevalence of obesity is expected to drive the growth of the diabetes diagnostics market in the coming years. Obesity is characterized by excessive accumulation of body fat, which raises the risk of several health conditions, including heart disease and diabetes. The growing incidence of obesity is linked to factors such as sedentary lifestyles, higher consumption of processed and high-calorie foods, genetic predisposition, and reduced physical activity. Diabetes diagnostics play a crucial role in obesity management by identifying insulin resistance and glucose metabolism issues early, allowing for timely interventions to prevent weight gain and associated health complications. For example, in September 2023, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, 22 states had an adult obesity rate of 35% or higher, up from 19 states in 2021. This increasing obesity rate is contributing to the expansion of the diabetes diagnostics market.

Companies operating in the diabetes diagnostics market are focusing on developing innovative products, such as gestational diabetes diagnostic tools, to broaden their product offerings and meet the rising demand for early detection and management of diabetes during pregnancy. These tools include medical devices and tests designed to detect and monitor gestational diabetes in pregnant women, often involving blood glucose testing, such as the oral glucose tolerance test (OGTT), to evaluate how the body processes sugar during pregnancy. For instance, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, introduced the XpressGT RUO kit, a cutting-edge biosensor tool for detecting insulin resistance-related conditions, including gestational diabetes, endometriosis, and liver disease. This kit provides rapid results by measuring 2-hydroxybutyrate (2-HB) levels in venous blood and is compatible with standard clinical analyzers. This innovation is designed to facilitate early diagnostics, potentially improving health outcomes for millions of patients worldwide.

In September 2023, Abbott Laboratories Ltd., a US-based medical device company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. This acquisition aims to strengthen Abbott's position in diabetes care, expand its FreeStyle Libre portfolio, and advance its efforts in developing connected solutions for more personalized and precise diabetes management. Bigfoot Biomedical Inc. is a US-based medical technology company focused on creating innovative solutions for insulin management.

Major players in the diabetes diagnostics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, 3M Company, Medtronic plc, Regeneron Pharmaceuticals Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, DexCom Inc, Santen Pharmaceutical Co. Ltd., Topcon Corporation, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, Optos plc, Bioland Technology Ltd, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, and DarioHealth Corp.

North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in diabetes diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diabetes diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diabetes diagnostics market consists of revenues earned by entities by providing services such as insulin sensitivity and resistance testing, neuropathy testing services, retinopathy screening services, and diabetes risk assessment services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetes diagnostics market also includes sales of glucose monitoring devices, HbA1c testing kits, and insulin pumps. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetes Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetes diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diabetes diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diabetes diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Blood Glucose Meters; Continuous Glucose Monitoring Devices; Lancets; Test Strips; Other Product Types
  • 2) By Diabetes Type: Diabetes I; Diabetes II; Gestational Diabetes
  • 3) By End-User: Hospitals; Diagnostic Centers; Homecare Settings; Other End-Users
  • Subsegments:
  • 1) By Blood Glucose Meters: Traditional Blood Glucose Meters; Smart Blood Glucose Meters; Bluetooth-enabled Blood Glucose Meters
  • 2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems; Implantable CGM Systems; Flash Glucose Monitoring Devices
  • 3) By Lancets: Single-use Lancets; Multi-use Lancets
  • 4) By Test Strips: Standard Test Strips; Smart Test Strips
  • 5) By Other Product Types: Hemoglobin A1c Testing Kits; Urine Glucose Test Strips; Blood Ketone Meters
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; Bayer AG; Abbott Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diabetes Diagnostics Market Characteristics

3. Diabetes Diagnostics Market Trends And Strategies

4. Diabetes Diagnostics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Diabetes Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Diabetes Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Diabetes Diagnostics Market Growth Rate Analysis
  • 5.4. Global Diabetes Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Diabetes Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Diabetes Diagnostics Total Addressable Market (TAM)

6. Diabetes Diagnostics Market Segmentation

  • 6.1. Global Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Meters
  • Continuous Glucose Monitoring Devices
  • Lancets
  • Test Strips
  • Other Product Types
  • 6.2. Global Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diabetes I
  • Diabetes II
  • Gestational Diabetes
  • 6.3. Global Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Homecare Settings
  • Other End-Users
  • 6.4. Global Diabetes Diagnostics Market, Sub-Segmentation Of Blood Glucose Meters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Blood Glucose Meters
  • Smart Blood Glucose Meters
  • Bluetooth-enabled Blood Glucose Meters
  • 6.5. Global Diabetes Diagnostics Market, Sub-Segmentation Of Continuous Glucose Monitoring Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wearable CGM Systems
  • Implantable CGM Systems
  • Flash Glucose Monitoring Devices
  • 6.6. Global Diabetes Diagnostics Market, Sub-Segmentation Of Lancets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-use Lancets
  • Multi-use Lancets
  • 6.7. Global Diabetes Diagnostics Market, Sub-Segmentation Of Test Strips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Test Strips
  • Smart Test Strips
  • 6.8. Global Diabetes Diagnostics Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemoglobin A1c Testing Kits
  • Urine Glucose Test Strips
  • Blood Ketone Meters

7. Diabetes Diagnostics Market Regional And Country Analysis

  • 7.1. Global Diabetes Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Diabetes Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diabetes Diagnostics Market

  • 8.1. Asia-Pacific Diabetes Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diabetes Diagnostics Market

  • 9.1. China Diabetes Diagnostics Market Overview
  • 9.2. China Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diabetes Diagnostics Market

  • 10.1. India Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diabetes Diagnostics Market

  • 11.1. Japan Diabetes Diagnostics Market Overview
  • 11.2. Japan Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diabetes Diagnostics Market

  • 12.1. Australia Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diabetes Diagnostics Market

  • 13.1. Indonesia Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diabetes Diagnostics Market

  • 14.1. South Korea Diabetes Diagnostics Market Overview
  • 14.2. South Korea Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diabetes Diagnostics Market

  • 15.1. Western Europe Diabetes Diagnostics Market Overview
  • 15.2. Western Europe Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diabetes Diagnostics Market

  • 16.1. UK Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diabetes Diagnostics Market

  • 17.1. Germany Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diabetes Diagnostics Market

  • 18.1. France Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diabetes Diagnostics Market

  • 19.1. Italy Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diabetes Diagnostics Market

  • 20.1. Spain Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diabetes Diagnostics Market

  • 21.1. Eastern Europe Diabetes Diagnostics Market Overview
  • 21.2. Eastern Europe Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diabetes Diagnostics Market

  • 22.1. Russia Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diabetes Diagnostics Market

  • 23.1. North America Diabetes Diagnostics Market Overview
  • 23.2. North America Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diabetes Diagnostics Market

  • 24.1. USA Diabetes Diagnostics Market Overview
  • 24.2. USA Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diabetes Diagnostics Market

  • 25.1. Canada Diabetes Diagnostics Market Overview
  • 25.2. Canada Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diabetes Diagnostics Market

  • 26.1. South America Diabetes Diagnostics Market Overview
  • 26.2. South America Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diabetes Diagnostics Market

  • 27.1. Brazil Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diabetes Diagnostics Market

  • 28.1. Middle East Diabetes Diagnostics Market Overview
  • 28.2. Middle East Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diabetes Diagnostics Market

  • 29.1. Africa Diabetes Diagnostics Market Overview
  • 29.2. Africa Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diabetes Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Diabetes Diagnostics Market Competitive Landscape
  • 30.2. Diabetes Diagnostics Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Diabetes Diagnostics Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. 3M Company
  • 31.3. Medtronic plc
  • 31.4. Regeneron Pharmaceuticals Inc.
  • 31.5. Carl Zeiss Meditec AG
  • 31.6. Bausch & Lomb Incorporated
  • 31.7. DexCom Inc
  • 31.8. Santen Pharmaceutical Co. Ltd.
  • 31.9. Topcon Corporation
  • 31.10. Tandem Diabetes Care Inc
  • 31.11. Ypsomed AG
  • 31.12. LifeScan Inc
  • 31.13. Nova Biomedical Corporation
  • 31.14. Ascensia Diabetes Care Holdings AG
  • 31.15. ARKRAY Inc

32. Global Diabetes Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetes Diagnostics Market

34. Recent Developments In The Diabetes Diagnostics Market

35. Diabetes Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Diabetes Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Diabetes Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Diabetes Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer